Recent guidelines that lower the threshold for hypertension treatment likely will raise costs by increasing the number of people receiving treatment, PBM executives say. But data show the wide range of generic medications available in the class could moderate those cost increases. In addition, it’s far better to treat people with hypertension than to leave […]
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.